For someone who has lived with depression for many years, the prospect of feeling better can become increasingly difficult to imagine. They may have tried several antidepressants, attended psychotherapy, made changes to their lifestyle and followed the advice of the professionals supporting them, yet still find themselves waking each morning with the same overwhelming sense of sadness, emptiness or exhaustion.
Perhaps even more difficult is the gradual loss of confidence that anything will help. People can reach a point where they no longer expect to feel happy, motivated or interested in the things they once enjoyed. Sometimes their ambition becomes simply to get through the day without feeling quite so overwhelmed.
This is one of the reasons why research into treatments capable of producing relatively rapid changes in depressive symptoms has attracted considerable attention. For some people, conventional antidepressants offer substantial relief, but they generally require several weeks before their therapeutic effects become apparent. When someone is already struggling to function, the prospect of waiting another month to discover whether a different medication will help can feel particularly daunting.
Research into ketamine has challenged some of the traditional assumptions about how quickly antidepressant effects can occur. Clinical studies have demonstrated that certain patients, including some with treatment-resistant depression, can experience measurable improvements within hours of receiving treatment.
However, understanding what this means requires more than focusing on speed alone. There are important questions about how ketamine works, why some people respond while others do not, how long improvements last, and whether psychotherapy has a role in helping people make use of any changes they experience.
When Depression Becomes a Way of Life
Depression is often described in terms of low mood, loss of interest, fatigue and negative thinking. While these are familiar features of the condition, they do not always convey what it feels like to live with depression over an extended period.
For some people, depression becomes so familiar that they begin to regard it as part of their personality. They may struggle to remember a time when life felt genuinely enjoyable or when ordinary activities did not require considerable effort. Relationships can become difficult to maintain, ambitions gradually disappear, and experiences that once brought pleasure may begin to feel strangely distant.
There can also be a profound sense of disconnection from oneself. People sometimes describe knowing intellectually that they love their family, appreciate their circumstances or have reasons to feel hopeful, yet finding themselves unable to experience the emotions that would ordinarily accompany those thoughts.
This distinction between knowing something and being able to feel it is particularly important. Depression is not simply a collection of negative ideas that can be corrected through positive thinking. It involves complex changes in emotional processing, motivation, cognition and biological functioning, together with psychological and social factors that differ considerably from one person to another.
For some individuals, depression is closely associated with difficult life experiences, unresolved grief, chronic stress or longstanding patterns of self-criticism. For others, the biological and psychological contributors are less obvious. Frequently, several factors interact.
When depression has persisted despite treatment, an individual’s confidence in their capacity to recover can become affected as well. The difficulty is no longer simply that they feel depressed, but that they increasingly struggle to imagine themselves feeling any other way.
It is within this context that the possibility of a relatively rapid antidepressant response becomes especially interesting.
Why the Speed of Ketamine’s Effects Has Attracted Attention
Most conventional antidepressants influence neurotransmitter systems involving serotonin, noradrenaline or other chemicals associated with mood regulation. Although their pharmacological effects begin earlier, meaningful improvement in depressive symptoms often takes several weeks.
Ketamine works differently. Its principal pharmacological action involves the glutamate system, particularly through its effects on NMDA receptors. Glutamate plays an important role in neural communication, learning and the ability of connections within the brain to adapt.
Research suggests that ketamine can influence signalling pathways associated with synaptic plasticity, the process through which connections between nerve cells are modified and reorganised. These processes are of particular interest because depression has been associated with alterations in neural functioning and connectivity, although the relationship between these findings and an individual’s experience of depression remains complex.
What has attracted the greatest clinical attention is the speed at which antidepressant effects have sometimes been observed. In controlled studies, some participants have experienced measurable reductions in depressive symptoms within hours, with improvements often assessed at approximately 24 hours following treatment.
This does not mean that everyone experiences an immediate improvement, or that the response is necessarily dramatic. Some individuals report considerable changes, others experience more modest benefits, and some do not respond at all. The duration of improvement also varies, and symptoms can return after the initial response.
Nevertheless, these findings have opened an important area of psychiatric research. They suggest that significant changes in depressive symptoms do not always require the prolonged period traditionally associated with conventional antidepressant medication.
For someone who has spent years feeling emotionally trapped, that possibility may be particularly meaningful.
What Does Rapid Improvement Actually Feel Like?
Clinical research generally measures antidepressant effects using structured assessment scales. These allow researchers to examine changes in mood, motivation, sleep, thinking and other symptoms associated with depression.
However, scores on a clinical questionnaire do not necessarily capture the personal significance of improvement.
For someone experiencing longstanding depression, a change may initially be quite subtle. They might notice that getting out of bed requires less effort, that familiar worries feel less consuming, or that they are able to enjoy a conversation without continually retreating into their own thoughts.
Others may describe a greater sense of emotional distance from problems that previously felt overwhelming. The circumstances of their life may remain unchanged, but their relationship with those circumstances feels temporarily different.
There is an important distinction here between experiencing an antidepressant effect and undergoing a psychedelic or dissociative experience. Ketamine can produce alterations in perception, awareness and the sense of self, but these experiences are not reliable indicators of whether someone will subsequently experience an improvement in depression.
An intense experience is not necessarily a therapeutic one, and a relatively uneventful session does not mean the treatment has been ineffective.
Similarly, although some people describe substantial emotional relief following treatment, others find the experience difficult to interpret or notice only gradual changes over subsequent days.
The important question is not simply what happens during the medicine session, but whether there is a meaningful improvement in the person’s symptoms, functioning and quality of life.
Why Rapid Relief Is Not Necessarily Lasting Relief
One of the limitations identified in ketamine research concerns the duration of its antidepressant effects.
A person may experience significant improvement following treatment, only for some or all of their depressive symptoms to return over the following days or weeks. Others maintain improvements for longer periods, sometimes with additional treatment, although the long-term evidence for repeated courses remains less established than the evidence for short-term antidepressant effects.
This variability is important because the speed of response can sometimes receive more attention than the question of what happens afterwards.
Depression is rarely explained by a single biological process. Although medication may influence systems associated with mood regulation, a person’s emotional wellbeing is also shaped by their relationships, environment, physical health, personal history and ways of responding to stress.
Someone may experience a reduction in depressive symptoms while continuing to live with the same unresolved difficulties that affected them before treatment. Those difficulties may include longstanding grief, problems establishing boundaries, chronic anxiety, emotional avoidance or painful beliefs about themselves that developed much earlier in life.
Of course, these factors do not explain every case of depression, nor does their presence mean that medication cannot produce sustained improvement. Depression is a medical condition as well as a psychological experience, and it is important not to reduce it to a problem that can simply be resolved through personal insight.
However, where psychological factors form part of someone’s difficulties, there may be considerable value in addressing them alongside appropriate medical care.
This brings us to the potential role of psychotherapy.
Where Does Psychotherapy Fit Into the Picture?
Ketamine-assisted psychotherapy combines medically supervised ketamine treatment with a structured psychological process that may include preparation, therapeutic support during sessions and subsequent integration.
The rationale is that any reduction in depressive symptoms, together with changes in emotional processing or perspective that some people experience, may provide opportunities for psychological work that previously felt difficult.
Consider someone who has spent much of their life believing that they are inadequate. They may understand where this belief originated and recognise that it is unreasonable, but the emotional conviction remains. They continue to interpret criticism as confirmation of their inadequacy, struggle to accept praise and place enormous pressure on themselves to avoid disappointing others.
If their depression temporarily becomes less overwhelming, they may find it easier to examine these familiar patterns. They might begin to recognise how much of their behaviour has been organised around avoiding rejection, or how frequently they mistake another person’s disappointment for evidence that they have done something wrong.
Psychotherapy provides a framework for exploring these experiences and considering how different responses might be developed.
This does not mean that ketamine automatically makes psychotherapy more effective. Although the combination is an active area of research, studies have not yet established that adding psychotherapy consistently produces better or longer-lasting antidepressant outcomes than ketamine treatment alone.
The clinical rationale is nevertheless understandable. Psychological change often involves more than recognising a problem. It requires developing different ways of relating to thoughts, emotions, memories and other people, and applying those changes in everyday life.
The period following an improvement in depressive symptoms may provide an opportunity to undertake some of this work, particularly when depression has previously made reflection, emotional engagement or behavioural change difficult.
In this sense, the potential value of combining medication and psychotherapy is not simply about making the antidepressant effect last longer. It is also about exploring whether improvements in mood and functioning can support a broader process of psychological recovery.
The Importance of Preparation and Integration
An altered state of consciousness is not necessarily therapeutic in itself. Experiences during ketamine treatment can range from relatively subtle changes in perception to profound dissociation, and their psychological significance varies considerably.
Preparation involves helping someone understand what treatment may involve, discussing their expectations and concerns, and establishing a supportive therapeutic relationship. It also provides an opportunity to explore their personal history, current difficulties and the changes they hope to make.
This is particularly relevant for people who have experienced trauma or who find uncertainty, vulnerability or loss of control difficult to tolerate. Although ketamine may produce experiences that some people regard as meaningful, it can also provoke anxiety, confusion or emotional discomfort. Appropriate medical assessment, monitoring and psychological support are therefore important considerations.
Integration takes place after the medicine session and is concerned with understanding the experience in the context of the person’s wider life.
Sometimes there may be an important personal insight to explore. On other occasions, integration is less about interpreting the experience itself and more about recognising changes in mood, behaviour or emotional responses, and considering how these can be supported.
For example, someone who has begun to feel less overwhelmed by depression may want to reconnect with friends, re-establish routines or return to activities they previously enjoyed. Another person may find themselves more able to explore unresolved emotional experiences in psychotherapy.
These changes are not always immediate or straightforward. Even when someone begins to feel better, established habits and patterns of avoidance can remain remarkably persistent.
Recovery frequently involves gradual adjustments, and psychological support may be useful in helping people navigate those adjustments without expecting every improvement to be permanent or every setback to represent failure.
Rapid Treatment Does Not Mean a Quick Fix
The suggestion that depression might improve within hours is understandably compelling, particularly for people who have spent months or years searching for relief. However, it is essential to distinguish the possibility of a rapid antidepressant response from the much broader process of recovery.
Ketamine is not an appropriate treatment for everyone. It requires careful clinical assessment and carries potential risks, including increases in blood pressure, dissociation, nausea and other adverse effects. Repeated exposure also raises questions about longer-term safety, including possible urinary and cognitive complications, and the potential for misuse or dependence.
There are additional considerations for individuals with certain cardiovascular conditions, psychiatric histories or other medical risk factors. Treatment decisions therefore require qualified medical oversight and an individual assessment of potential benefits and risks.
In the United Kingdom, ketamine is licensed as an anaesthetic but not for the treatment of depression. Its use for depression is therefore off-label. This distinction matters because promising research findings do not automatically mean that a treatment has established long-term effectiveness or regulatory approval for a particular condition.
Similarly, although ketamine-assisted psychotherapy is attracting growing clinical and scientific interest, research into the combination remains at an earlier stage than research into ketamine’s short-term pharmacological antidepressant effects.
None of this diminishes the importance of investigating new approaches. Rather, it reinforces the need for realistic expectations, informed consent and a clear understanding of what is known, what remains uncertain and what alternatives are available.
Looking Beyond the Speed of Treatment
For someone living with severe or persistent depression, the possibility of feeling better relatively quickly can be enormously significant. Even a period of improvement may allow them to reconnect with aspects of life that have felt inaccessible, regain some confidence in their capacity to function, or begin engaging with psychological work that previously seemed overwhelming.
At the same time, depression does not always disappear simply because symptoms temporarily improve. People may still need support in understanding their difficulties, rebuilding relationships, addressing practical circumstances or developing ways of managing future periods of distress.
The growing interest in ketamine has opened important questions about the biological mechanisms of depression and the possibility of more rapid antidepressant responses. Research into ketamine-assisted psychotherapy adds a further question: whether changes in mood, perception and emotional processing can be meaningfully incorporated into a wider psychological treatment process.
The answers are still developing, and it would be premature to suggest that either medication alone or its combination with psychotherapy offers a universally effective solution.
What matters is that treatment is considered in the context of the whole person, rather than simply the speed at which symptoms might change.
For anyone who has lived with depression for a long time, recovery is not necessarily about returning to the person they were before becoming unwell. It may also involve gradually rebuilding a sense of connection, developing a different understanding of themselves and rediscovering possibilities that depression had made difficult to imagine.
The prospect of rapid relief is an important part of the research. Understanding how that relief relates to meaningful and sustainable recovery is the challenge that remains.
WRITTEN BY
Paul Gibson
Psychotherapist and Director of Psychotherapeutic Services at The Emerge Clinic. Paul has more than 15 years’ experience supporting people through depression, anxiety, trauma, and addiction, with a particular interest in ketamine-assisted psychotherapy and psychological integration.
- Medically reviewed by Dr Devany
- October 8, 2026